Isla Pharmaceuticals, Inc. — Form D
Isla Pharmaceuticals, Inc. of SAN JUAN, PR, a company, filed a Form D exempt-offering notice with the SEC on 2018-11-15. The offering totals $1.1M, of which $1.1M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-11-15
- Form: D
- Accession: 0001758855-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $1.1M
- Amount sold: $1.1M
- Minimum investment: $6K
- Investors: 16
- Date of first sale: 2018-03-01
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-325928
Issuer
- Name: Isla Pharmaceuticals, Inc.
- CIK: 0001758855
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 100 CALLE DEL MUELLE, 21007, SAN JUAN, PR, 00901
- Phone: 510-393-6523
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| David Charles Foster | Director | Euless, TX |
| David Charles Foster | Executive Officer | Euless, TX |
| Albert Charles Hansen | Director | Henderson, NV |
| Paul Donald Richard MacLeman | Director | Loch Vic, C3 |
| Joseph Isadore Green | Director | Staten Island, NY |
| William James Garner | Director | San Juan, PR |
Other filings by this issuer (2)
More